These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection. Braselton WE; Bransome ED; Huff TA Diabetes; 1977 Jan; 26(1):50-7. PubMed ID: 830565 [TBL] [Abstract][Full Text] [Related]
4. Thermal dissociation of sulfonylureas. Dissociation of tolbutamide in a series of aliphatic alcohols and in polyethylene glycol 400. Bottari F; Mannelli M; Saettone MF J Pharm Sci; 1970 Nov; 59(11):1663-6. PubMed ID: 5500449 [No Abstract] [Full Text] [Related]
6. The pharmacology of sulfonylureas. Skillman TG; Feldman JM Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of catecholamine release by tolbutamide and other sulfonylureas. Hsu CY; Brooker G; Peach MJ; Westfall TC Science; 1975 Mar; 187(4181):1086-7. PubMed ID: 1114337 [TBL] [Abstract][Full Text] [Related]
8. Sulfonylureas rapidly cross phospholipid bilayer membranes by a free-diffusion mechanism. Kamp F; Kizilbash N; Corkey BE; Berggren PO; Hamilton JA Diabetes; 2003 Oct; 52(10):2526-31. PubMed ID: 14514636 [TBL] [Abstract][Full Text] [Related]
9. Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas. Ehlhardt WJ; Woodland JM; Worzalla JF; Bewley JR; Grindey GB; Todd GC; Toth JE; Howbert JJ Chem Res Toxicol; 1992; 5(5):667-73. PubMed ID: 1446007 [TBL] [Abstract][Full Text] [Related]
10. Interactions of sulfonylureas with plasma proteins. Hsu PL; Ma JK; Luzzi LA J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196 [No Abstract] [Full Text] [Related]
11. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C. Tian YA; Johnson G; Ashcroft SJ Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541 [TBL] [Abstract][Full Text] [Related]
12. Stoichiometry of calcium binding by hypoglycemic sulfonylureas. Deleers M; Brasseur R; Malaisse WJ Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):181-201. PubMed ID: 6658185 [TBL] [Abstract][Full Text] [Related]
14. THE ACTION OF SULFONYLUREAS IN PRODUCING HYPOGLYCEMIA. WILENSKY AS Ala J Med Sci; 1964 Jan; 1():83-91. PubMed ID: 14192740 [No Abstract] [Full Text] [Related]
15. Clinical and experimental findings after five years' treatment of diabetes with sulfonylureas. MEHNERT H Diabetes; 1962; 11(Suppl)():80-4. PubMed ID: 13934500 [No Abstract] [Full Text] [Related]
18. Effects of sulfonylureas on membrane-bound low Km cyclic AMP phosphodiesterase in rat fat cells. Osegawa M; Makino H; Kanatsuka A; Kumagai A Biochim Biophys Acta; 1982 Nov; 721(3):289-96. PubMed ID: 6293588 [TBL] [Abstract][Full Text] [Related]
19. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685 [TBL] [Abstract][Full Text] [Related]